M2 PHARMA-March 24, 2015-Allium Medical's
Embolic Protection Filter System Meets Early Stage Study Objectives
created a parametric model of an
embolic protection filter, based on a high resolution microCT scan of a 4 mm diameter Angioguard filter (Cordis, J&J) using pyFormex (Conti, in press).
Recommended Usage: Self-expanding nitinol stent, used with an
embolic protection filter to capture emboli during the stenting procedure.
Recommended Usage: Self-expanding nitinol stent, used with an
embolic protection filter (the Emboshield Embolic Protection System) to capture emboli during the stenting procedure.
During 1 year of follow-up, patients who were treated with this stent along with the
embolic protection filter had a 9.
NYSE: MDT), today announced CE (Conformite Europeene) mark approval and the European market launch of the Defender
embolic protection filter for use during minimally invasive procedures in carotid arteries and saphenous vein grafts.
50 per share if Rubicon develops a stroke therapy device that meets certain stringent independent testing requirements prior to March 31, 2006 (discussed above) and an additional $1 per share if net sales of Rubicon's
embolic protection filter exceed $50 million in any 12-month period during the five years following the later of Rubicon's receipt of FDA approval of the Rubicon Filter and the closing date of Boston Scientific's acquisition of all the Rubicon shares.
As a result, the Rubicon Filter is designed with an ultra-low crossing profile providing cardiologists and interventional radiologists with the ability to deliver the Rubicon Filter past many blockages in blood vessels not previously navigable with other
embolic protection filter delivery systems.
As a result, the Rubicon Filter is designed with an ultra-low crossing profile, providing cardiologists and interventional radiologists with the ability to deliver the Rubicon Filter past many blockages in blood vessels not previously navigable with other
embolic protection filter delivery systems.
Complete Carotid Solution' Now Includes Innovative System Combining Exponent Carotid Stent and Interceptor(R) PLUS Carotid
Embolic Protection Filter System
Any forward-looking statements involve risks and uncertainties, including risks and uncertainties pertaining to Rubicon's ability to complete development and obtain regulatory approvals for its
embolic protection filter, its lack of control over whether Boston Scientific exercises any options that have been granted to it, uncertainties with respect to its ability to achieve performance milestones, and the other risks and uncertainties described in the company's filings with the Securities and Exchange Commission, that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, whether as a result of new information, future events or otherwise.
Martin Leon, president and CEO of the Cardiovascular Research Foundation (CRF) in New York City, the organization that organizes and manages TCT, stated, "The Rubicon Filter is the smallest profile
embolic protection filter in the world, and we are very pleased to have Dr.
